This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Christine Lebouteiller: Innovator in Pharmaceutical Chemistry
Introduction
Christine Lebouteiller is a notable inventor based in Pechabou, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of drugs aimed at preventing tumor cell proliferation. Her innovative work has garnered attention in the scientific community.
Latest Patents
Christine holds a patent for the use of amines to produce drugs that combat tumor cell proliferation. The patent details the use of compounds capable of displacing tritiated cis-N-cyclohexyl-N-ethyl [3-(3-chloro-4-cyclohexylphenyl)-allyl]amine from its receptors for the preparation of pharmaceutical compositions intended to inhibit cell proliferation. This invention represents a crucial advancement in cancer treatment.
Career Highlights
Christine is associated with Sanofi-Synthelabo, a leading global healthcare company. Her work at the company has allowed her to focus on innovative solutions in drug development. With her expertise, she has contributed to the advancement of pharmaceutical sciences.
Collaborations
Christine has collaborated with esteemed colleagues such as Jean C Breliere and Pascual Ferrara. These partnerships have enhanced her research and development efforts, leading to impactful innovations in the field.
Conclusion
Christine Lebouteiller's contributions to pharmaceutical chemistry and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire future research in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile